Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca2+

Hepatology Research

Volumn 40, Issue 4, 2010, Pages 424-431

  Yuan, Yufeng ^a   Liu, Jun ^a   Liu, Zhisu ^a   He, Yueming ^a   Zhang, Zhonglin ^a   Jiang, Congqing ^a   Qian, Qun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Ca2+; Chemokine CCL3; Hepatocellular carcinoma

Indexed keywords

CALCIUM; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77954362046     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00619.x     Document Type: Article

References (34)

1. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19(3):271-85.
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127(1):S5-16. Suppl
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362(9399):1907-17.
4. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, screening. Semin Liver Dis 2005, 25(2):143-54.
5. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999, 340(10):798-9.
6. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-76.
7. Mazzanti R, Gramantieri L, Bolondi L. Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 2008, 29(1-2):130-43.
8. Blum H. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 2005, 11:7391-400.
9. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007, 25:787-820.
10. Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 2006, 79(4):639-51.
11. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12(2):121-7.
12. Holm NT, Abreo F, Johnson LW, Li BD, Chu QD. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Res Treat 2009, 113(2):293-9.
13. Sugasawa H, Ichikura T, Tsujimoto H. Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer. J Surg Oncol 2008, 97(5):445-50.
14. Watanabe H, Miki C, Okugawa Y, Toiyama Y, Inoue Y, Kusunoki M. Decreased expression of monocyte chemoattractant protein-1 predicts poor prognosis following curative resection of colorectal cancer. Dis Colon Rectum 2008, 51(12):1800-5.
15. Matsuo Y, Ochi N, Sawai H. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009, 124(4):853-61.
16. Iwakiri S, Mino N, Takahashi T. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I non-small cell lung cancer. Cancer 2009, 115(11):2580-93.
17. Silva TA, Ribeiro FL, Oliveira-Neto HH. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: Implications in tumor metastasis and local host defense. Oncol Rep 2007, 18(5):1107-13.
18. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 2006, 210(3):363-73.
19. Ghadjar P, Loddenkemper C, Coupland SE. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 2008, 134(11):1181-9.
20. Ehtesham M, Mapara KY, Stevenson CB, Thompson RC. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 2009, 274(2):305-12.
21. Lu P, Nakamoto Y, Nemoto-Sasaki Y. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 2003, 162(4):1249-58.
22. Yang X, Lu P, Fujii C. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer 2006, 118(8):1869-76.
23. Wu XF, Fan J, Wang XY. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochem Biophys Res Commun 2007, 355(4):866-71.
24. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2(8):563-72.
25. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007, 98(11):1652-8.
26. Muller A, Homey B, Soto H. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-6.
27. Zlotnik A. Chemokines and cancer. Int J Cancer 2006, 119:2026-9.
28. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci 2005, 96:317-22.
29. Murakami T, Cardones AR, Hwang ST. Chemokine receptors and melanoma metastasis. J Dermatol Sci 2004, 36:71-8.
30. Rubie C, Frick VO, Wagnery M. Enhanced expression and clinical significance of CC-chemokine MIP-3a in hepatocellular carcinoma. Scand J Immunol 2006, 63:468-77.
31. Kubo F, Ueno S, Hiwatashi K. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol 2005, 12(10):800-7.
32. Nelson TE, Gruol DL. The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J Neuroimmunol 2004, 156(1-2):74-87.
33. Yang SX, Chen JH, Jiang XF. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun 2005, 335(2):523-8.
34. Massa A, Casagrande S, Bajetto A. SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent cytosolic tyrosine kinase Pyk2. Ann NY Acad Sci 2006, 1090:385-98.